TXN's Q3 Gross Margin Surpasses 64%, but Full Recovery Already Priced In

What happened

Texas Instruments reported Q3 2026 gross margin of 64.2%, a sharp improvement from 57.4% a year ago and 61.4% in the prior quarter, driven by higher revenue, pricing, factory loadings and product mix. This is consistent with the company's earlier Q3 results and reflects the ongoing analog recovery, with industrial and automotive demand remaining strong. However, the stock has already surged 55% over the past year and trades at 36.2x earnings and 32.1x EV/EBITDA, indicating the market has priced in much of this margin expansion. Management described 2026 pricing as 'early and not very significant,' and inventory levels remain elevated at 194 days, posing a risk if demand softens. The key question for further margin improvement hinges on whether 2027 pricing negotiations yield tangible price increases and whether industrial and automotive demand stay broad enough to keep new 300mm capacity well utilized.

Implication

The margin strength confirms the operational leverage from TXN's internal 300mm manufacturing, but it does not change the view that the stock offers no margin of safety at current levels. Investors should monitor the January 2027 earnings call for explicit details on 2027 pricing negotiations; a failure to confirm pricing gains would undermine the margin-expansion thesis. Inventory days must stabilize or decline from the current 194 level, and management must continue to name industrial and automotive as growth drivers. Until these indicators confirm, the risk-reward remains balanced, and a better entry point near $250 or below offers a more attractive payoff. The pending Silicon Labs acquisition also adds integration and financing risk that warrants caution.

Thesis delta

The thesis remains WAIT with no material shift. The article simply confirms the gross margin improvement already captured in the master report, but does not provide new evidence that would alter the valuation or risk assessment. The core issue remains whether TXN can convert its manufacturing advantage into sustained pricing and demand, which will only be validated in early 2027.